Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Another Blood Pressure Drug Recalled Under Carcinogen Scare
11/16/2018
An angiotensin II receptor blocker indicated, alone or in combination with other drugs, for the treatment of hypertension is being recalled.
An angiotensin II receptor blocker indicated, alone or in combination with other drugs, for the treatment of hypertension is being recalled.
An angiotensin II receptor...
11/16/2018
Pharmacy Learning Network
News
Are SGLT2 Inhibitors Linked to Amputation, Ketoacidosis Risk?
11/16/2018
Researchers examined the risk of lower limb amputation and diabetic ketoacidosis among patients using SGLT2 inhibitors. 
Researchers examined the risk of lower limb amputation and diabetic ketoacidosis among patients using SGLT2 inhibitors. 
Researchers examined the risk of...
11/16/2018
Pharmacy Learning Network
News
CDC: What To Look For in Acute Flaccid Myelitis
11/15/2018
As the number of confirmed cases in the US continues to rise, a new report from the CDC details common signs and symptoms associated with acute flaccid myelitis.
As the number of confirmed cases in the US continues to rise, a new report from the CDC details common signs and symptoms associated with acute flaccid myelitis.
As the number of confirmed cases...
11/15/2018
Pharmacy Learning Network

Advertisement

News
ATS Opposes FDA Approval of Over-the-Counter Epinephrine
11/14/2018
The American Thoracic Society says it opposes the FDA’s recent approval of an over-the-counter epinephrine option for consumer use to treat asthma.
The American Thoracic Society says it opposes the FDA’s recent approval of an over-the-counter epinephrine option for consumer use to treat asthma.
The American Thoracic Society...
11/14/2018
Pharmacy Learning Network
News
Side Effects From Immune Checkpoint Inhibitors may be More Common Than Thought
11/14/2018
Immune-related side effects with immune checkpoint inhibitors may be more common than reported in the initial trials that led to their approval, according to recent data.
Immune-related side effects with immune checkpoint inhibitors may be more common than reported in the initial trials that led to their approval, according to recent data.
Immune-related side effects with...
11/14/2018
Pharmacy Learning Network
News
Many US Drugstores Fail to Provide Naloxone for Opioid Overdoses
11/13/2018
Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two studies suggest many pharmacies don't stock the drug or make it easily available to people who need it.
Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two studies suggest many pharmacies don't stock the drug or make it easily available to people who need it.
Despite state laws expanding...
11/13/2018
Pharmacy Learning Network

Advertisement

News
Fish Oil, Vitamin D Pills No Guard Against Cancer, Serious Heart Trouble
11/12/2018
A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems.
A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems.
A widely anticipated study has...
11/12/2018
Pharmacy Learning Network
News
Low-Dose Methotrexate Fails to Lower Risk of Heart Attack, Stroke
11/12/2018
A drug used to treat anti-inflammatory diseases failed to show that a low-dose of the drug can reduce the risk of heart attack or stroke.
A drug used to treat anti-inflammatory diseases failed to show that a low-dose of the drug can reduce the risk of heart attack or stroke.
A drug used to...
11/12/2018
Pharmacy Learning Network
News
AstraZeneca`s Diabetes Drug Curbs Heart Failure, Kidney Risks
11/12/2018
The biggest clinical trial so far to assess a new class of diabetes pills shows that a drug can prevent heart failure and cut the risk of kidney problems in a broad range of patients.
The biggest clinical trial so far to assess a new class of diabetes pills shows that a drug can prevent heart failure and cut the risk of kidney problems in a broad range of patients.
The biggest clinical trial so...
11/12/2018
Pharmacy Learning Network

Advertisement

News
New Drug Options, Risk Factors Added to U.S. Heart Guidelines
11/12/2018
Updated guidelines on heart health advise more personalized assessment of risk as well as two newer types of cholesterol-lowering drugs for people at particularly high risk of heart attack or stroke.
Updated guidelines on heart health advise more personalized assessment of risk as well as two newer types of cholesterol-lowering drugs for people at particularly high risk of heart attack or stroke.
Updated guidelines on heart...
11/12/2018
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use